MakeMyTrip (MMYT) has just completed large equity and 0.00% convertible senior notes offerings, raising billions in fresh capital. This increases cash reserves and introduces the prospect of future share dilution for existing shareholders.

These capital raises arrive after a sharp 30-day share price return of 30.07% and a 90-day share price return of 49.86%. However, the year-to-date share price return is down 29.97%, and the 1-year total shareholder return has declined 40.04%, pointing to rebuilding momentum after a weak year.

If this kind of sharp swing in sentiment has you looking beyond MakeMyTrip, it could be a good moment to widen your watchlist and check out 20 top founder-led companies

Bulls will point to MakeMyTrip’s fresh capital, recent share price rebound and analyst price target gap, while bears focus on dilution risk and a weak 1 year return. So which side does the valuation actually support next?

Most Popular Narrative: 18.9% Undervalued

MakeMyTrip's most followed narrative pegs fair value at $70.73 versus a last close of $57.35, framing the analyst discussion around growth, margins and risk.

Ongoing investment in product innovation, particularly in AI-powered personalization and user experience improvements, positions MakeMyTrip for higher conversion rates, better customer retention, and ultimately supports expanding net margins through improved operating leverage.

Curious what earnings profile sits behind that fair value, and why analysts still see room despite rich multiples and recent volatility? The full narrative lays out revenue cadence, margin ambitions and the discount rate that ties it together.

Result: Fair Value of $70.73 (UNDERVALUED)

However, MakeMyTrip’s narrative still faces pressure from high customer acquisition costs and concentrated exposure to India, factors that could quickly unsettle both margin assumptions and growth expectations.

Another View: Market Pricing Versus MakeMyTrip Fair Ratio

While the analyst narrative frames MakeMyTrip as 18.9% undervalued, the market’s current P/E of 105x tells a different story. It sits far above the US Hospitality average of 23.8x and also above a fair ratio of 56.6x, which points to meaningful valuation risk if sentiment cools.

For investors comparing these signals, the gap between today’s P/E, peers and the fair ratio raises a simple question: is the market overpaying for growth that may already be in the price, or is this kind of premium exactly what strong expectations deserve?

Next Steps

With both risks and rewards in play for MakeMyTrip, how confident are you in the story so far, and are you ready to pressure test it against the underlying data and sentiment yourself? To see the mix of concerns and positives flagged by the market, review the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond MakeMyTrip?

If MakeMyTrip has sharpened your focus on valuation and risk, do not stop there. Broaden your opportunity set with targeted stock lists built from clear fundamentals.

• Target income potential by reviewing companies in the 8 dividend fortresses that may suit investors who want yield with a clear starting point.
• Strengthen your downside protection by scanning the 74 resilient stocks with low risk scores and focus on businesses with more resilient profiles.
• Spot early opportunities before the crowd by working through the screener containing 18 high quality undiscovered gems and seeing which stories deserve a place on your radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.